New hope for kids with Tough-to-Treat cancer

NCT ID NCT05027386

Recruiting now Disease control Sponsor: Sun Yat-sen University Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding a drug called apatinib to standard chemotherapy can help children and teenagers whose neuroblastoma has come back or hasn't responded to previous treatments. The trial will involve up to 125 participants aged 5-18 years old. Researchers want to find the safest dose and see if this combination can shrink tumors and help patients live longer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Yizhuo Zhang
RECRUITING

Guangzhou, Guangdong, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NEUROBLASTOMA